Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DRL_TC
- Development stage
- Phase 1
- Lead developer
- Dr. Reddy's Laboratories
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Subcutaneous, Intravenous
01
Overview
DRL_TC is a biosimilar of tocilizumab, a recombinant humanized monoclonal antibody that targets the interleukin-6 (IL-6) receptor. Developed by Dr. Reddy's Laboratories, it is intended for the treatment of inflammatory conditions such as rheumatoid arthritis and giant cell arteritis. The drug works by binding to both soluble and membrane-bound IL-6 receptors, thereby inhibiting IL-6-mediated signaling, which plays a key role in the pathogenesis of various autoimmune diseases. DRL_TC is being developed in both subcutaneous and intravenous formulations and has demonstrated pharmacokinetic equivalence to the reference products Actemra and RoActemra in Phase 1 clinical trials. A global Phase 3 study is currently underway to evaluate its efficacy and safety in patients with moderate to severe active rheumatoid arthritis.
- Other names
- tocilizumab biosimilar
02
Targets
IL-6R (Interleukin-6 receptor subunit alpha)
Beyond the preview
Go deeper on DRL_TC.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DRL_TC.